Snibe

Snibe specializes in developing and manufacturing clinical laboratory instruments—primarily automated chemiluminescence immunoassay analyzers—and a broad menu of supporting reagents covering over a hundred parameters. Their products are widely used globally for diagnosing endocrine disorders, metabolic conditions like diabetes and kidney disease, infectious diseases including hepatitis/HIV/syphilis as well as oncology applications such as tumor marker detection. The company has achieved significant international regulatory milestones—including FDA clearance—and continues to expand its pipeline with new diagnostic parameters targeting global health needs through ongoing R&D collaborations with academic institutions.